In three of the 107 MND patients (i.e., 2.8%), a biallelic pathogenic (AAGGG)exp repeat expansion in RFC1 was detected, one of which was previously reported by us [15]. This evidence concerns the gene RFC1 and mild neurocognitive disorder.